EPS beat and membership growth — UnitedHealth Group trades around $334 in price forecast

Traders Union
All News
Financial News
Unitedhealth rises 0.18% today

Highlights

UnitedHealth Group trades at $334.31, below its MA-20 ($358.60), MA-50 ($343.98), and MA-200 ($385.42), confirming persistent multi-horizon selling pressure.
Third-quarter revenues surpassed $113 billion, up 12% year-over-year, while UnitedHealth faces a U.S. Department of Justice Medicare billing investigation with potential financial risks.
Bearish technicals dominate as all major oscillators signal oversold conditions and sellers control price action, limiting upside near the Ichimoku Kijun at $353.87.

DOJ probe and growth in memberships raise earnings and risk profile

UnitedHealth Group reported third-quarter revenues above $113 billion, marking a 12% increase year-over-year as domestic memberships expanded. The company is currently under a U.S. Department of Justice investigation concerning Medicare billing practices, raising potential financial risks. UnitedHealth also surpassed its EPS estimate, maintained a dividend payout ratio of about 46%, and saw ongoing activity from institutional investors and insiders.

Downside momentum prevails as resistance firms and oscillators show oversold

The technical setup remains weak, with UNH trading under all major moving averages, reinforcing downside momentum. The Ichimoku Kijun at $353.87 acts as the nearest resistance, while no strong support is identified above the present price. Momentum indicators are mixed — MACD is neutral, ADX reflects limited bullish drive, but most oscillators, including RSI at 35.69, Stoch RSI at zero, and a sharply negative CCI, signal oversold conditions. Intraday, sellers maintain control, as indicated by oversold BBP and support from the Awesome Oscillator for the prevailing bearish tone.

Limited rebound chances as range-bound action and resistance cap upside

Over the coming week, UNH is likely to move within a narrow range of $342.47 to $344.86, centered around $343.66. The probability of a price rise remains low, with sideways action anticipated between dynamic resistance at $353.87 and key support zones. A bullish scenario would require a firm breakout above the Ichimoku Kijun, while a bearish case would see prices dip under immediate support, exposing recent lows below $330.

Viktoras Karapetjanc, expert at Traders Union, sees UnitedHealth Group’s solid revenue growth and institutional involvement as supportive factors, despite current technical weakness and regulatory headwinds. He believes the robust third-quarter performance and expanding membership offer medium-term optimism, though short-term sentiment is pressured by the ongoing DOJ investigation and oversold momentum indicators. While the stock remains under key moving averages, Karapetjanc maintains a cautiously constructive view, watching for a potential rebound if resistance near $353.87 is cleared. "If UnitedHealth can resolve regulatory uncertainties and hold its financial momentum, I expect sentiment to improve and the stock to challenge higher ranges in the coming weeks."

Previously it was noted that mixed momentum and range-bound action were observed, highlighting indecision among buyers and sellers. Last time we reported that the probability of an immediate breakout remained low according to momentum indicators.

Source of Data: UNH Price Analysis by TU

The analysis is based on a proprietary model combining technical, on-chain, and expert data. Not investment advice. See methodology

The information is based on forecasts and does not constitute investment advice or a guarantee of future results. Market conditions may change. See our Disclaimer and Editorial Integrity for details.